Effective IB control starts early, relies on precision, and succeeds through integration. Photo: Ceva
Effective IB control starts early, relies on precision, and succeeds through integration. Photo: Ceva

Integrated IBV control: Vaccination, monitoring and prevention

Santé Animale
Ceva Santé Animale Company profile
15-04 | |
Effective IB control starts early, relies on precision, and succeeds through integration. Photo: Ceva
Effective IB control starts early, relies on precision, and succeeds through integration. Photo: Ceva

Infectious bronchitis virus (IBV) remains one of the most economically damaging diseases in modern poultry production. Affecting both broilers and layers, IBV is highly contagious and difficult to control due to its rapid evolution and interaction with other respiratory pathogens.

Ceva’s integrated IB solution, which is centered around broad-spectrum vaccines, optimised hatchery vaccination technology, and robust monitoring programs, aims to address these challenges through a comprehensive and scientifically validated approach.

IBV epidemiology and its evolutionary challenge

IBV shows strong genetic variability, especially in the S1 gene, which promotes rapid mutation and recombination. This drives variability in circulating strains and the continual emergence of new variants. Demonstrating documented cross-protection across this broad spectrum is therefore essential.

Field surveillance highlights the complexity of IBV circulation. Frequently co-infections were documented with IBV correlated to other agents as Mycoplasma spp., E. coli, ILTV, NDV, and avian influenza strains.

The integrated IB control concept

There is a holistic approach based on 3 pillars:

1. Vaccination quality and simplification

Ensuring homogeneous protection from day 1 through high-precision hatchery vaccination systems (e.g., Desvac sprayers with flat nozzle technology) that improve spray coverage, droplet size uniformity, and vaccine‑take.

2. Disease control

Broad-spectrum cross‑protection against multiple genotypes, supported by data management and epidemiological monitoring.

3. Disease prevention

Reducing virus shedding and environmental pressure through robust early-life immunity.

This integrated system aligns with modern poultry production models that require consistent, scalable, and replicable IB control strategies.

The role of hatchery vaccination – it all starts from the hatchery

High-quality day‑old vaccination is essential for optimal IB control. And this technology focuses on:

  • Crate coverage
  • Droplet homogeneity
  • Proper droplet size

These factors are critical to achieving high vaccine‑take, as illustrated in field monitoring.

Conclusion: Integration as the new standard

As poultry production systems intensify globally, disease challenges such as IBV will continue to evolve. Fragmented approaches are no longer sufficient.

IBV control demands a comprehensive, scientifically validated strategy. An integrated IB solution – combining smart combination of vaccines, hatchery vaccination technology, and data-driven monitoring – provides:

  • Early and long-lasting immunity
  • Broad genotype cross-protection
  • Significant reduction in virus shedding and environmental pressure
  • Reduced transmission of virus

For producers and integrators, the message is clear: effective IB control starts early, relies on precision, and succeeds through integration.

Santé Animale
Ceva Santé Animale Company profile

Ceva Santé Animale (Ceva) is the 5th global animal health company, led by experienced veterinarians, whose mission is to provide innovative health solutions for all animals to ensure the highest level of care and well-being. Our portfolio includes preventive medicine such as vaccines, pharmaceutical and animal welfare products for farm and companion animals, as well as equipment and services to provide the best experience for our customers. With 6,500 employees located in 47 countries, Ceva strives daily to bring to life its vision as a OneHealth company: “Together, beyond animal health”. 2022 turnover: €1.53 billion. Use the links below to learn more about Ceva.

Santé Animale
Ceva Santé Animale Company profile

Ceva Santé Animale (Ceva) is the 5th global animal health company, led by experienced veterinarians, whose mission is to provide innovative health solutions for all animals to ensure the highest level of care and well-being. Our portfolio includes preventive medicine such as vaccines, pharmaceutical and animal welfare products for farm and companion animals, as well as equipment and services to provide the best experience for our customers. With 6,500 employees located in 47 countries, Ceva strives daily to bring to life its vision as a OneHealth company: “Together, beyond animal health”. 2022 turnover: €1.53 billion. Use the links below to learn more about Ceva.